Goldman Expects AMD to Cut its FY Forecast This Month, Says Headwinds are Priced In
- Wall Street ends sharply higher after Powell comments
- Salesforce (CRM) shares slide despite topping earnings, revenue expectations
- Fed's Powell: Rate hikes to slow, but adjustment just beginning
- Snowflake shares plunge 13% despite Q3 beat
- Market turmoil and economic decline, before recovery in 2023, says JPM's Kolanovic
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Goldman Sachs analyst Toshiya Hari cut price targets on Advanced Micro Devices (NASDAQ: AMD) and Intel (NASDAQ: INTC) to reflect slashed CPU volume assumptions. The PC market is experiencing near-term weakness; hence estimates are lowered to reflect the ongoing market trends.
The price target on AMD is cut to $88 per share from $112, while Hari also expects the chipmaker to cut its full-year revenue and earnings (implied) outlook later this month. Still, the analyst remains bullish on AMD shares, looking past these near-term headwinds.
“We believe the near-term headwinds are well-understood at this point, and as such, we maintain our Buy rating on the stock with 33% potential upside to our updated 12-month price target,” Hari told clients in a note.
“We foresee share growth in the server CPU market driving above-industry revenue growth and margin expansion for AMD. Importantly, we expect that AMD can maintain its recent momentum in the server CPU market.”
Similarly, Hari also slashed the price target on Intel to $24 per share (from $30) while reaffirming the Sell rating.
“We expect the implementation of the CHIPS and Science Act and renewed opex management to only partially offset the decline in earnings and FCF stemming from lower CPU volumes and under-utilization charges.”
AMD and Intel shares are still up 3% and 1.7%, respectively, in pre-open trading Tuesday.
By Senad Karaahmetovic
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Analysts impressed by Biogen (BIIB) after full data on Alzheimer's drug Lecanemab
- XPO Logistics (XPO) valuation compelling but macro headwinds dampen growth - Citi
- Alphabet (GOOGL) may be volatile in the near-term - Mizuho
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change, Hot Comments, Hot List
Related EntitiesGoldman Sachs, Earnings, Pre Market Movers, Senad Karaahmetovic
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!